Pioneering Cellular Immunotherapies for Cancer and Auto Immune Disorders

At Immunex Shield, we harness the power of your immune system to combat cancer and immune disorders through cutting-edge cellular therapies. 

Our NextGen Cellular Therapies

Natural Killer (NK) Cell Therapy

About

Natural killer cell - Wikipedia

Natural Killer cells are your body’s first line of defense against cancer and viral infections. Our proprietary NK cell enhancement technology amplifies these powerful immune warriors to recognize and eliminate cancer cells with unprecedented efficiency.

How NK Cell Therapy Works:

  1. We extract NK cells from your blood or from healthy donors
  2. Our proprietary activation process enhances the cells’ cancer-fighting abilities
  3. The supercharged NK cells are expanded to therapeutic quantities
  4. These enhanced cells are infused back into your body to seek and destroy cancer cells

Our NK cell therapy has shown remarkable results in treating:

  • Hematological malignancies
  • Solid tumors
  • Treatment-resistant cancers

Why Immunex Shield?

Personalized Medicine Approach

Personalized Medicine Approach

Every patient’s immune system and disease are unique. Our therapies are customized based on:

  • Patient specific Tumour antigens, immunogenetics and disease profile
  • Your immune system’s characteristics
  • Gut Microbiome Epigenetics/Genetics analysis of your disease
No Side Effects

No Side Effects

Unlike traditional cancer treatments that damage healthy immune cells, our immunotherapies work with your body’s natural defenses, resulting in:
  • Reduced systemic toxicity
  • Preservation of healthy tissue
  • Improved quality of life during treatment
Cutting-Edge Research

Cutting-Edge Research

Our team of immunologists, oncologists, and cellular therapy experts continuously advance our platforms through:

  • Proprietary cell activation technologies
  • Novel targeting mechanisms
  • Enhanced cell persistence techniques
  • Combination therapy approaches
ImmunexShield - Orbital Network (Rotating, Light BG)
ImmunexShield
TMB/MSI
T/B cell epitopes & Peptides
PD-L1/CTLA4 Scores
Primary Cancer Cells
Circulating Tumor Cells
Tumor Exosomes
Gut Microbiome
ImmunexShield - Advanced Immunoprofiling

ImmunexShield

Advanced Immunoprofiling Solutions

Tumor Mutation Burden
Microsatellite Instability
PDL1/CTLA Scores
Primary Cancer Cells
Circulating Tumor Cells
Tumor Exosomes
Gut Microbiome

Research and Innovation

Immunex Shield is committed to advancing the field of cellular immunotherapy through:

Next-Generation Platforms

  • Development of off-the-shelf NK cell products
  • Multi-targeted CAR constructs
  • Antigen discovery

Strategic Partnerships

Collaborations with leading academic institutions and biotechnology companies to accelerate breakthrough treatments.

Expanding Indications

Research into applying our cellular therapies to autoimmune disorders, infectious diseases, and age-related immune dysfunction.